Loading stock data…
GRDN
$37.37+0.27 (+0.73%)
Market ClosedLast close May 1
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Guardian Pharmacy Services, Inc. in the Healthcare sector is trading at $37.37. The stock is currently near its 52-week high of $41.36, remaining 26.0% above its 200-day moving average. Technical signals show neutral RSI of 36 and bearish MACD signal, explaining why GRDN maintains its current momentum and trend strength. The Whystock Score of 100/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Neutral momentum (RSI 36) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$37.37
Potential Downside
51%
Whystock Fair Value$18.32
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.33B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
46.49
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
23.92%
Volume
Today's trading volume
179,591
Recent News
Guardian Pharmacy Services to Report Q1 Earnings: What's in the Cards?
GRDN heads into Q1 earnings with revenues seen at $329.7M, as growth trends, vaccine volumes and IRA pricing impacts take center stage.
Stevanato Group (STVN) Reports Next Week: Wall Street Expects Earnings Growth
Stevanato (STVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Guardian Pharmacy Services (GRDN) Reports Next Week: Wall Street Expects Earnings Growth
Guardian Pharmacy (GRDN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Assessing Guardian Pharmacy Services (GRDN) Valuation After Strong Recent Share Price Momentum
Guardian Pharmacy Services: Recent Performance Snapshot Guardian Pharmacy Services (GRDN) has caught investor attention after recent trading, with the stock last closing at US$37.54 and recent returns showing mixed moves over the past week, month and past 3 months. See our latest analysis for Guardian Pharmacy Services. The recent 1-day share price return of 1.6% comes after a 7-day share price return of 4.1% and a 30-day share price return of 10.7%, contributing to a 27.1% year to date share...
Silence Therapeutics (SLN) Soars 19.0%: Is Further Upside Left in the Stock?
Silence Therapeutics (SLN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.